The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+ gastric or gastro-esophageal junction cancer (TOXAG study).
 
Huseyin Abali
Honoraria - Roche
 
Suayib Yalcin
No Relationships to Disclose
 
Huseyin Cem Onal
No Relationships to Disclose
 
Faysal Dane
Honoraria - Roche
 
Berna Oksuzoglu
Honoraria - Roche
 
Nuriye Ozdemir
No Relationships to Disclose
 
Huseyin Mertsoylu
No Relationships to Disclose
 
Mehmet Artac
No Relationships to Disclose
 
Celalettin Camci
No Relationships to Disclose
 
Bulent Karabulut
Honoraria - Roche
 
Fatma Bugdayci Basal
No Relationships to Disclose
 
Burcin Budakoglu
No Relationships to Disclose
 
Mehmet Ali Nahit Sendur
No Relationships to Disclose
 
Burce Goktas
Employment - Roche
 
Fatih Ozdener
Employment - Roche
Leadership - Roche
 
Arzu Calisgan
Consulting or Advisory Role - Roche